PHA MEDICAL EDUCATION
ON-DEMAND PROGRAMS
A Meeting of the New Jersey Association of Osteopathic Physicians and Surgeons
Suspecting Pulmonary Hypertension in the Dyspneic Patient:
Who, When, and How
Wednesday, February 24, 2021
6:30 – 7:30 pm est Webinar
Presenter:
K. Akaya Smith, MD
Assistant Professor of Clinical Medicine
Perelman School of Medicine at the
University of Pennsylvania
Medical Director, Pulmonary
Hypertension Program
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Zoom Link:
https://zoom.us/meeting/register/tJAvduitq
zwqEtLNSvRSQ-kd8Ko9S6JqNvR5
Educational Objectives
This CME program is designed to improve competence,
performance, and patient care practices by instructing
clinicians in the highest quality of care for patients with
PAH. At the conclusion of this program, participants will
be able to:
n Accurately diagnose patients through comprehensive
screening and early recognition of symptoms
n Evaluate the patient’s condition and prescribe
optimal long-term management, including knowing
when and how to treat and when to consult with
colleagues at an established PAH center
Target Audience
This activity has been designed for pulmonologists,
cardiologists, rheumatologists, internists, and
primary care physicians, as well as nurses, physician
assistants, and other allied health professionals
who help care for patients with pulmonary arterial
hypertension (PAH).
Accreditation
In support of improving patient
care, this activity has been planned
and implemented by Washington
University School of Medicine in
St. Louis, Continuing Medical
Education and the Pulmonary Hypertension Association.
Washington University School of Medicine in St. Louis
is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation
Council for Pharmacy Education (ACPE), and the American
Nurses Credentialing Center (ANCC), to provide continuing
education for the healthcare team.
Credit Awarded for This Activity
Washington University School of Medicine in St. Louis
designates this internet live activity for a maximum of
1 AMA PRA Category 1 CreditTM. Physicians should claim
only the credit commensurate with the extent of their
participation in the activity
This activity is supported by educational grants from:
Platinum Level Gold Level
Janssen Pharmaceuticals, Inc. United Therapeutics Corporation